You skip over a spot where you bled because it looks painful. That consideration leaves plaque exactly where it should be ...
A study of a personalized vaccine combined with an existing immunotherapy found the treatment helped patients with melanoma avoid cancer recurrence. The combination trains the patient's immune system ...
After graduating from Western University of Health Sciences, she worked in emergency and general practice before startin… ...
She earned her DVM and PhD in comparative and molecula… A food allergy happens when a dog’s immune system overreacts to a ...
Sept 25 (Reuters) - Merck (MRK.N), opens new tab and Daiichi Sankyo (4568.T), opens new tab have withdrawn their US application seeking accelerated approval for an experimental lung cancer therapy, ...
SAN DIEGO, Oct. 7, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or the "Company") announced today that the specialized Dutch patent court of the Hague has found Merck to ...
Sept 24 (Reuters) - Merck (MRK.N), opens new tab said on Thursday its injectable drug for a serious eye disease affecting people with diabetes was as effective as the current standard treatment in ...
Version History is a show about the best gadgets ever. And the worst ones. And the ones that might have changed the world, if they ever actually shipped. Every week, your favorite people from The ...
Merck will present data at the American Academy of Ophthalmology Annual Meeting next month. (Angus Liu/Fierce Pharma) Merck & Co.’s Brunello trial has hit its primary endpoint, shedding light on the ...
In this episode of Everyday Wild, we explain how to identify Megalopyge opercularis, where it lives, what it becomes, why it is often found on oak, elm, and citrus trees, and what to do if you ...
After the release of Vision Pro, everyone wanted to know how long it would be before the company could release a lighter version that isn’t so bulky on your face. For the longest time, we had been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results